$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Global License

Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 26 Mar 2015 | 41417 | In Stock

Introduction

The global pharmacovigilance and drug safety software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. North America region held the largest share of the pharmacovigilance and drug safety software market in 2014. However, Asian and Latin American countries symbolize high growth markets. This is owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

The growth of the global pharmacovigilance and drug safety software market is mainly driven by increasing incidence rates of adverse drug reactions (ADRs), growing adoption of pharmacovigilance software by outsourcing companies (such as CROs and BPOs), and huge pressure on pharma companies to develop novel and safe drugs. However, the dearth of standard regulations and lack of pharmacovigilance professionals are some of the key factors restraining the growth of this market.

In this report, the global pharmacovigilance and drug safety software market has been classified into four segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. The global pharmacovigilance and drug safety software market is segmented into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

The global pharmacovigilance and drug safety software market comprises large number of small and mid-size software developers and service providers. As of 2014, the global pharmacovigilance and drug safety software market was dominated by Oracle Corporation (U.S.).

New service launches; agreements, and partnerships; software developments; and geographical expansions are some of the major strategies adopted by most of the market players to achieve growth in the pharmacovigilance and drug safety software market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis —industry analysis (value chain analysis and Porter’s five force model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the pharmacovigilance and drug safety software market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them to garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned four strategies (market penetration, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on pharmacovigilance and drug safety software offered by the top 10 players in the pharmacovigilance and drug safety software market. The report analyzes the pharmacovigilance and drug safety software market on the basis of functionality, delivery mode, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pharmacovigilance and drug safety software across geographies.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmacovigilance and drug safety software market.

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the pharmacovigilance and drug safety software market.

Table of Contents
for Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019

  • TABLE OF CONTENTS

    1 INTRODUCTION 15

    1.1 OBJECTIVES OF THE STUDY 15

    1.2 MARKET DEFINITION 15

    1.3 MARKET SCOPE 15

    1.3.1 MARKETS COVERED 16

    1.3.2 YEARS CONSIDERED FOR THE STUDY 17

    1.4 CURRENCY 17

    1.5 LIMITATIONS 17

    1.6 STAKEHOLDERS 18

    2 RESEARCH METHODOLOGY 19

    2.1 RESEARCH DATA 19

    2.1.1 SECONDARY DATA 20

    2.1.1.1 Key data from secondary sources 20

    2.1.2 PRIMARY DATA 21

    2.1.2.1 Key data from primary sources 21

    2.1.2.2 Key industry insights 22

    2.1.2.3 Breakdown of primaries 22

    2.2 MARKET SIZE ESTIMATION 23

    2.2.1 BOTTOM-UP APPROACH 23

    2.2.2 TOP-DOWN APPROACH 24

    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25

    2.4 RESEARCH ASSUMPTIONS 26

    2.4.1 ASSUMPTIONS 26

    3 EXECUTIVE SUMMARY 27

    3.1 INTRODUCTION 27

    3.2 CURRENT SCENARIO 28

    3.3 FUTURE OUTLOOK 29

    3.4 CONCLUSION 30

    4 PREMIUM INSIGHTS 31

    4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 31

    4.2 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY FUNCTIONALITY 32

    4.3 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 33

    4.4 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 34

    5 MARKET OVERVIEW 35

    5.1 INTRODUCTION 36

    5.2 MARKET SEGMENTATION 36

    5.2.1 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

    BY FUNCTIONALITY 36

    5.2.2 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

    BY DELIVERY MODE 37

    5.2.3 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

    BY END USER 37

    5.3 MARKET DYNAMICS 38

    5.3.1 KEY MARKET DRIVERS 38

    5.3.1.1 Intensification of drug safety regulations by government authorities 38

    5.3.1.2 Heavy clinical R&D expenditure by the pharmaceutical industry 39

    5.3.1.3 Benefits offered by PV solutions—reduced cost and time involved in clinical trial processes 39

    5.3.1.4 Government grants to support clinical trials 39

    5.3.1.5 Large investments in healthcare IT by governments from mature as well as developing nations 40

    5.3.2 KEY MARKET RESTRAINTS 41

    5.3.2.1 Dearth of healthcare IT professionals 41

    5.3.2.2 Cultural differences and language barriers 42

    5.3.3 KEY MARKET OPPORTUNITIES 42

    5.3.3.1 Cloud technology provides opportunities for industry players 42

    5.3.3.2 Emerging markets to offer high growth opportunities 42

    5.3.4 KEY MARKET CHALLENGES 43

    5.3.4.1 Lack of standardization and harmonization of drug safety regulations 43

    5.3.4.2 Low adoption of pharmacovigilance solutions in the least developed countries 43

    6 INDUSTRY INSIGHTS 45

    6.1 INTRODUCTION 45

    6.2 PORTER’S FIVE FORCES ANALYSIS 45

    6.2.1 THREAT FROM NEW ENTRANTS 46

    6.2.2 THREAT FROM SUBSTITUTES 47

    6.2.3 BARGAINING POWER OF SUPPLIERS 47

    6.2.4 BARGAINING POWER OF BUYERS 48

    6.2.5 INTENSITY OF COMPETITIVE RIVALRY 48

    6.3 INDUSTRY TRENDS 49

    6.3.1 STRONG FOCUS ON NEW PRODUCT LAUNCHES 49

    6.3.2 GROWING MARKET PREFERENCE FOR CLOUD-BASED PLATFORMS 49

    7 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

    BY FUNCTIONALITY 50

    7.1 INTRODUCTION 51

    7.2 ADVERSE EVENT REPORTING SOFTWARE 52

    7.3 DRUG SAFETY AUDIT SOFTWARE 53

    7.4 FULLY INTEGRATED SOFTWARE 53

    7.5 ISSUE TRACKING SOFTWARE 54

    8 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

    BY DELIVERY MODE 55

    8.1 INTRODUCTION 56

    8.2 ON-PREMISE DELIVERY MODE 57

    8.3 ON-DEMAND/CLOUD-BASED (SAAS) DELIVERY MODE 57

    9 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 59

    9.1 INTRODUCTION 60

    9.2 CONTRACT RESEARCH ORGANIZATIONS (CROS) 61

    9.3 PHARMA AND BIOTECH COMPANIES 62

    9.4 BUSINESS PROCESS OUTSOURCING (BPO) FIRMS 63

    9.5 OTHER PHARMACOVIGILANCE SERVICE PROVIDERS 64

    10 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 66

    10.1 INTRODUCTION 67

    10.2 NORTH AMERICA 68

    10.2.1 U.S. 71

    10.2.2 CANADA 73

    10.3 EUROPE 75

    10.3.1 GERMANY 78

    10.3.2 U.K. 80

    10.3.3 FRANCE 81

    10.3.4 REST OF EUROPE 83

    10.4 ASIA-PACIFIC 84

    10.4.1 JAPAN 87

    10.4.2 CHINA 89

    10.4.3 INDIA 90

    10.4.4 REST OF ASIA-PACIFIC 92

    10.5 ROW (REST OF THE WORLD) 93

    10.5.1 LATIN AMERICA 95

    10.5.2 MIDDLE EAST 97

    10.5.3 AFRICA 98

    11 COMPETITIVE LANDSCAPE 101

    11.1 OVERVIEW 101

    11.2 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 102

    11.3 COMPETITIVE SITUATION AND TRENDS 103

    11.4 RECENT DEVELOPMENTS 104

    11.4.1 NEW PRODUCT LAUNCHES 104

    11.4.2 ACQUISITIONS, PARTNERSHIPS, AND AGREEMENTS 105

    11.4.3 NEW SERVICE LAUNCHES AND SERVICE EXPANSIONS 106

    11.4.4 GEOGRAPHICAL EXPANSIONS 106

    11.4.5 OTHER DEVELOPMENTS 107

    12 COMPANY PROFILES 108

    12.1 INTRODUCTION 108

    12.2 ORACLE CORPORATION 108

    12.2.1 BUSINESS OVERVIEW 108

    12.2.2 PRODUCT PORTFOLIO 109

    12.2.3 KEY STRATEGY 109

    12.2.4 RECENT DEVELOPMENTS 109

    12.2.5 SWOT ANALYSIS 110

    12.3 ARISGLOBAL LLC 111

    12.3.1 BUSINESS OVERVIEW 111

    12.3.2 PRODUCTS & SERVICES 111

    12.3.3 KEY STRATEGY 112

    12.3.4 RECENT DEVELOPMENTS 112

    12.3.5 SWOT ANALYSIS 114

    12.4 EXTEDO GMBH 115

    12.4.1 BUSINESS OVERVIEW 115

    12.4.2 PRODUCTS & SERVICES 115

    12.4.3 KEY STRATEGY 115

    12.4.4 SWOT ANALYSIS 116

    12.5 AB-CUBE 117

    12.5.1 BUSINESS OVERVIEW 117

    12.5.2 PRODUCT & SERVICES 117

    12.5.3 KEY STRATEGY 117

    12.6 ENNOV SOLUTIONS, INC. 118

    12.6.1 BUSINESS OVERVIEW 118

    12.6.2 PRODUCTS & SERVICES 118

    12.6.3 KEY STRATEGY 118

    12.6.4 RECENT DEVELOPMENTS 119

    12.7 ONLINE BUSINESS APPLICATIONS, INC. 120

    12.7.1 BUSINESS OVERVIEW 120

    12.7.2 PRODUCTS & SERVICES 120

    12.7.3 KEY STRATEGY 120

    12.7.4 RECENT DEVELOPMENTS 121

    12.8 SARJEN SYSTEMS PVT. LTD. 122

    12.8.1 BUSINESS OVERVIEW 122

    12.8.2 PRODUCTS & SERVICES 122

    12.8.3 KEY STRATEGY 123

    12.9 SPARTA SYSTEMS, INC. 124

    12.9.1 BUSINESS OVERVIEW 124

    12.9.2 PRODUCTS & SERVICES 124

    12.9.3 KEY STRATEGY 124

    12.9.4 RECENT DEVELOPMENTS 125

    12.10 UMBRA GLOBAL, LLC 127

    12.10.1 BUSINESS OVERVIEW 127

    12.10.2 PRODUCTS & SERVICES 127

    12.10.3 KEY STRATEGY 127

    12.10.4 RECENT DEVELOPMENTS 128

    12.11 UNITED BIOSOURCE CORPORATION (AN EXPRESS SCRIPTS COMPANY) 129

    12.11.1 BUSINESS OVERVIEW 129

    12.11.2 SERVICES PORTFOLIO 129

    12.11.3 KEY STRATEGY 129

    12.11.4 RECENT DEVELOPMENTS 129

    13 APPENDIX 130

    13.1 INSIGHTS OF INDUSTRY EXPERTS 130

    13.2 DISCUSSION GUIDE 131

    13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 134

    13.4 AVAILABLE CUSTOMIZATIONS 134

    13.5 RELATED REPORTS 135

List Of Tables
in Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019

LIST OF TABLES


TABLE 1 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

BY FUNCTIONALITY, 2012–2019 ($MILLION) 52

TABLE 2 ADVERSE EVENT REPORTING SOFTWARE MARKET, BY REGION,

2012–2019 ($MILLION) 52

TABLE 3 DRUG SAFETY AUDIT SOFTWARE MARKET, BY REGION, 2012–2019 ($MILLION) 53

TABLE 4 FULLY INTEGRATED SOFTWARE MARKET, BY REGION 2012–2019 ($MILLION) 54

TABLE 5 ISSUE TRACKING SOFTWARE MARKET, BY REGION 2012–2019 ($MILLION) 54

TABLE 6 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

BY DELIVERY MODE 2012–2019 ($MILLION) 56

TABLE 7 ON-PREMISE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

BY REGION 2012–2019 ($MILLION) 57

TABLE 8 ON-DEMAND/CLOUD-BASED PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY REGION 2012–2019 ($MILLION) 58

TABLE 9 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012–2019 ($MILLION) 61

TABLE 10 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2012–2019 ($MILLION) 62

TABLE 11 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2012–2019 ($MILLION) 63

TABLE 12 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR BUSINESS PROCESS OUTSOURCING FIRMS, BY REGION, 2012–2019 ($MILLION) 64

TABLE 13 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE FOR OTHER SERVICE PROVIDERS, BY REGION, 2012–2019 ($MILLION) 65

TABLE 14 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 68

TABLE 15 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 70

TABLE 16 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 70

TABLE 17 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 71

TABLE 18 NORTH AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 71

TABLE 19 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 72

TABLE 20 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 72

TABLE 21 U.S.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 73

TABLE 22 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 74

TABLE 23 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 74

TABLE 24 CANADA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 74

TABLE 25 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY COUNTRY, 2012-2019 ($MILLION) 77

TABLE 26 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 77

TABLE 27 EUROPEAN PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 77

TABLE 28 EUROPE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 78

TABLE 29 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 79

TABLE 30 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 79

TABLE 31 GERMANY: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 79

TABLE 32 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 80

TABLE 33 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 81

TABLE 34 U.K.: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 81

TABLE 35 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 82

TABLE 36 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 82

TABLE 37 FRANCE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 83

TABLE 38 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 83

TABLE 39 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 84

TABLE 40 ROE: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 84

TABLE 41 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY COUNTRY, 2012-2019 ($MILLION) 86

TABLE 42 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 86

TABLE 43 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 87

TABLE 44 ASIA-PACIFIC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 87

TABLE 45 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 88

TABLE 46 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 88

TABLE 47 JAPAN: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 88

TABLE 48 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 89

TABLE 49 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 90

TABLE 50 CHINA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 90

TABLE 51 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 91

TABLE 52 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 91

TABLE 53 INDIA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 92

TABLE 54 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 92

TABLE 55 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 93

TABLE 56 ROAPAC: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 93

TABLE 57 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY REGION, 2012-2019 ($MILLION) 94

TABLE 58 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 94

TABLE 59 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 94

TABLE 60 ROW: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 95

TABLE 61 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 96

TABLE 62 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 96

TABLE 63 LATIN AMERICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 96

TABLE 64 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY FUNCTIONALITY, 2012-2019 ($MILLION) 97

TABLE 65 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY DELIVERY MODE, 2012-2019 ($MILLION) 98

TABLE 66 MIDDLE EAST: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 98

TABLE 67 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY FUNCTIONALITY, 2012-2019 ($MILLION) 99

TABLE 68 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY DELIVERY MODE, 2012-2019 ($MILLION) 99

TABLE 69 AFRICA: PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SIZE,

BY END USER, 2012-2019 ($MILLION) 100

TABLE 70 TOP 5 NEW PRODUCT LAUNCHES, 2012–2014 104

TABLE 71 TOP 5 ACQUISITIONS, PARTNERSHIPS, AND AGREEMENTS, 2012–2014 105

TABLE 72 TOP 5 NEW SERVICE LAUNCHES AND SERVICE EXPANSIONS, 2012–2014 106

TABLE 73 GEOGRAPHICAL EXPANSIONS, 2012–2014 107

TABLE 74 TOP 5 OTHER DEVELOPMENTS, 2012–2014 107

List Of Figures, Charts and Diagrams
in Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019

LIST OF FIGURES


FIGURE 1 RESEARCH DESIGN 19

FIGURE 2 BOTTOM-UP APPROACH 23

FIGURE 3 TOP-DOWN APPROACH 24

FIGURE 4 DATA TRIANGULATION 25

FIGURE 5 ASSUMPTIONS OF THE RESEARCH STUDY 26

FIGURE 6 ADVERSE EVENT REPORTING SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET OVER THE NEXT FIVE YEARS 27

FIGURE 7 NORTH AMERICA COMMANDED THE LARGEST SHARE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, 2014 28

FIGURE 8 THE ON-PREMISE DELIVERY MODE SEGMENT WILL DRIVE THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET DURING

2014–2019 29

FIGURE 9 THE CROS SEGMENT ACCOUNTED FOR A MAJOR SHARE OF THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET IN 2014 30

FIGURE 10 INTENSIFICATION OF DRUG SAFETY REGULATIONS BY GOVERNMENT BODIES IS PROPELLING THE MARKET GROWTH 31

FIGURE 11 ADVERSE EVENT REPORTING SOFTWARE SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL MARKET IN 2014 32

FIGURE 12 BUSINESS PROCESS OUTSOURCING (BPO) FIRMS TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 33

FIGURE 13 NORTH AMERICA DOMINATES THE GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 34

FIGURE 14 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET,

BY FUNCTIONALITY 36

FIGURE 15 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY DELIVERY MODE 37

FIGURE 16 PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET, BY END USER 37

FIGURE 17 INCREASING DRUG SAFETY REGULATIONS TO PROPEL THE DEMAND FOR PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE 38

FIGURE 18 INTENSIFICATION OF DRUG SAFETY REGULATIONS BY GOVERNMENT AUTHORITIES DRIVING MARKET GROWTH 41

FIGURE 19 DEARTH OF SKILLS AND EXPERTISE FOR CONDUCTING CLINICAL TRIALS RESTRAINING MARKET GROWTH 42

FIGURE 20 INCREASING DEMAND FOR CLOUD TECHNOLOGY, A NEW GROWING OPPORTUNITY FOR MARKET PLAYERS 43

FIGURE 21 LACK OF STANDARDIZATION AND HARMONIZATION OF DRUG SAFETY REGULATIONS IS A KEY CHALLENGE TO THE MARKET 44

FIGURE 22 PRESENCE OF LARGE NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IS DRIVING THE GROWTH OF THE MARKET 46

FIGURE 23 ADVERSE EVENT REPORTING SOFTWARE HOLDS LARGEST SHARE OF THE MARKET 51

FIGURE 24 ON-PREMISE DELIVERY MODE SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE IN THE MARKET DURING 2014–2019 56

FIGURE 25 CONTRACT RESEARCH ORGANIZATIONS (CROS) COMMANDED THE LARGEST MARKET SHARE IN THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET 60

FIGURE 26 NORTH AMERICA COMMANDS LION’S SHARE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET IN 2014 67

FIGURE 27 NORTH AMERICA MARKET SNAPSHOT: DEMAND WILL BE DRIVEN BY PRESENCE OF LARGE NUMBER OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 69

FIGURE 28 EUROPE MARKET SNAPSHOT: LARGE NUMBER OF ONGOING CLINICAL TRIALS IS KEY FACTOR TO DRIVE THE MARKET GROWTH 76

FIGURE 29 ASIA-PACIFIC MARKET SNAPSHOT: INCREASING PREFERENCE OF PHARMA COMPANIES TOWARDS APAC-BASED CROS FOR CLINICAL TRIALS WILL CONTINUE TO DRIVE THE MARKET GROWTH 85

FIGURE 30 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY FROM 2012 TO 2014 101

FIGURE 31 GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET SHARE,

BY KEY PLAYER, 2014 102

FIGURE 32 NEW PRODUCT LAUNCH WAS THE KEY STRATEGY 103

FIGURE 33 ORACLE CORPORATION: COMPANY SNAPSHOT 108

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

41417 | HIT 3268

Number of Pages

136

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Pharmacovigilance Software-Global Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Global Market Status and Trend Report 2013-2023 offers a co...
08 Jan 2018 by MIReports USD $2,480 More Info
Pharmacovigilance Software-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report SummaryPharmacovigilance Software-Global Market Status & Trend Report 2013-2023 Top 20 Countr...
08 Jan 2018 by MIReports USD $3,680 More Info
Pharmacovigilance Software-North America Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-North America Market Status and Trend Report 2013-2023 offe...
08 Jan 2018 by MIReports USD $3,480 More Info
Pharmacovigilance Software-South America Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-South America Market Status and Trend Report 2013-2023 offe...
08 Jan 2018 by MIReports USD $3,480 More Info
Pharmacovigilance Software-Europe Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Europe Market Status and Trend Report 2013-2023 offers a co...
08 Jan 2018 by MIReports USD $3,480 More Info
Pharmacovigilance Software-EMEA Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-EMEA Market Status and Trend Report 2013-2023 offers a comp...
08 Jan 2018 by MIReports USD $3,480 More Info
Pharmacovigilance Software-Asia Pacific Market Status and Trend Report 2013-2023
Report SummaryPharmacovigilance Software-Asia Pacific Market Status and Trend Report 2013-2023 offer...
08 Jan 2018 by MIReports USD $3,480 More Info
Global and Chinese Pharmacovigilance Drug Safety Software Industry, 2017 Market Research Report
The 'Global and Chinese Pharmacovigilance Drug Safety Software Industry, 2012-2022 Market Research R...
23 Dec 2017 by Prof Research USD $3,000 More Info
Pharmacovigilance Market: By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial); By Type of Service Providers (In House, Contract Outsourcing) & By Region-Forecast (2016-2022)
Pharmacovigilance is referred to as a practice of monitoring the effects of medical drugs after they...
23 Sep 2016 by USD $5,250 More Info
Pharmacovigilance Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2020
Future Market Insights offers a 6-year forecast of the global pharmacovigilance market between 2015 ...
04 Dec 2015 by Future Market Insights USD $5,000 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...